Abbott Laboratories (TSX:ABT)

Market Cap	299.29B
Revenue (ttm)	61.07B
Net Income (ttm)	19.40B
Shares Out	n/a
EPS (ttm)	11.09
PE Ratio	15.43
Forward PE	22.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	994
Open	22.19
Previous Close	22.19
Day's Range	22.19 - 22.19
52-Week Range	22.16 - 22.19
Beta	1.05
RSI	n/a
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Software - Application
• Sector: Technology
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD